JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Available iCS plus LABA combination products | Download Table
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
IMPACT Study Data | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium & vilanterol)
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Asthma & COPD Medications Chart - National Asthma Council Australia
ICS/LABA/LAMA per la BPCO è stata approvata in Europa • NCF
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Atti della Accademia Lancisiana - Numeri della Rivista
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
How Will The New GSK Respiratory Portfolio Fare In 2017? (NYSE:GSK) | Seeking Alpha
Understanding GlaxoSmithKline's Trelegy Ellipta (NYSE:GSK) | Seeking Alpha
Hoitopolut
Farmacoutilizzazione della terapia inalatoria nella Medicina Generale italiana
GSK 렐바 엘립타 시장 점유율 40% 돌파 < 제약산업 < 제약·유통 < 기사본문 - 의학신문
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
Proven mechanisms of action leading to synergistic or additive... | Download Scientific Diagram
Lama medication - garrytshirts
that have recently been approved in some countries or are currently... | Download Scientific Diagram
MEDI:GATE NEWS : GSK 트렐리지 엘립타, 성인 천식 환자 위한 3제 복합요법 치료제로 적응증 확대
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study - ScienceDirect
A new alphabet for COPD care | European Respiratory Society
Health Related Quality of Life | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
